Therefore, a large-scale trial of nutritional and exercise interventions is needed to establish a treatment strategy for sarcopenia in patients with LC, especially those with low serum BCAA and IGF-1 levels. Here, IGF1 is linked to laryngotracheoesophageal cleft.